ARGX
Price
$589.15
Change
-$4.32 (-0.73%)
Updated
Mar 28 closing price
Capitalization
36.36B
39 days until earnings call
BBIO
Price
$35.11
Change
-$1.29 (-3.54%)
Updated
Mar 28 closing price
Capitalization
6.68B
32 days until earnings call
Ad is loading...

ARGX vs BBIO

Header iconARGX vs BBIO Comparison
Open Charts ARGX vs BBIOBanner chart's image
argenx SE
Price$589.15
Change-$4.32 (-0.73%)
Volume$233.02K
Capitalization36.36B
BridgeBio Pharma
Price$35.11
Change-$1.29 (-3.54%)
Volume$1.19M
Capitalization6.68B
ARGX vs BBIO Comparison Chart
Loading...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARGX vs. BBIO commentary
Mar 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGX is a StrongBuy and BBIO is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 31, 2025
Stock price -- (ARGX: $589.15 vs. BBIO: $35.11)
Brand notoriety: ARGX and BBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARGX: 83% vs. BBIO: 40%
Market capitalization -- ARGX: $36.15B vs. BBIO: $6.68B
ARGX [@Biotechnology] is valued at $36.15B. BBIO’s [@Biotechnology] market capitalization is $6.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $307.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARGX’s FA Score shows that 1 FA rating(s) are green whileBBIO’s FA Score has 1 green FA rating(s).

  • ARGX’s FA Score: 1 green, 4 red.
  • BBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, ARGX is a better buy in the long-term than BBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARGX’s TA Score shows that 4 TA indicator(s) are bullish while BBIO’s TA Score has 5 bullish TA indicator(s).

  • ARGX’s TA Score: 4 bullish, 6 bearish.
  • BBIO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than ARGX.

Price Growth

ARGX (@Biotechnology) experienced а -4.21% price change this week, while BBIO (@Biotechnology) price change was +0.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was -8.21%, and the average quarterly price growth was -9.61%.

Reported Earning Dates

ARGX is expected to report earnings on May 08, 2025.

BBIO is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARGX($36.4B) has a higher market cap than BBIO($6.68B). BBIO YTD gains are higher at: 27.952 vs. ARGX (-4.203). ARGX has higher annual earnings (EBITDA): -60.47M vs. BBIO (-436.83M). ARGX has more cash in the bank: 3.1B vs. BBIO (681M). ARGX has less debt than BBIO: ARGX (34M) vs BBIO (1.73B). ARGX has higher revenues than BBIO: ARGX (1.86B) vs BBIO (222M).
ARGXBBIOARGX / BBIO
Capitalization36.4B6.68B545%
EBITDA-60.47M-436.83M14%
Gain YTD-4.20327.952-15%
P/E Ratio46.10N/A-
Revenue1.86B222M837%
Total Cash3.1B681M456%
Total Debt34M1.73B2%
FUNDAMENTALS RATINGS
ARGX: Fundamental Ratings
ARGX
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARGXBBIO
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
72%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
View a ticker or compare two or three
Ad is loading...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LW54.010.11
+0.20%
Lamb Weston Holdings
ESOA9.53-0.03
-0.31%
Energy Services of America Corp
STGW5.93-0.25
-4.05%
Stagwell
MODG6.53-0.37
-5.36%
Topgolf Callaway Brands Corp
AYRO0.55-0.06
-10.50%
AYRO

ARGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ARGNF. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
-0.73%
ARGNF - ARGX
55%
Loosely correlated
N/A
BBIO - ARGX
46%
Loosely correlated
-3.54%
IONS - ARGX
40%
Loosely correlated
-1.80%
AXON - ARGX
40%
Loosely correlated
-2.85%
ALNY - ARGX
38%
Loosely correlated
-0.94%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-3.54%
ARGX - BBIO
46%
Loosely correlated
-0.73%
AXON - BBIO
44%
Loosely correlated
-2.85%
ARRY - BBIO
43%
Loosely correlated
-0.59%
PMN - BBIO
43%
Loosely correlated
+0.00%
BPMC - BBIO
40%
Loosely correlated
-1.13%
More